Stocktoria
NP Life Sciences Health Industry Group Inc. ACAT
NP Life Sciences Health Industry Group Inc. (ACAT) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend. FY2023 revenue was $164,621 at a -1.8% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Services · percentile among 941 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Services companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ACAT | NP Life Sciences Health Industry Group Inc. | 3/9 | — | — | — |
| VSA | VisionSys AI Inc | 3/9 | -10.75 | — | -99.9% |
| RMGL | Rocky Mountains Group Ltd | 1/9 | 2.92 | — | — |
| RPDL | Rapid Line Inc. | 2/9 | — | — | — |
| EDTK | Skillful Craftsman Education Technology Ltd | 3/9 | — | — | — |
| DWAY | Driveitaway Holdings, Inc. | 2/9 | — | — | — |
| KPEA | Kun Peng International Ltd. | 3/9 | — | — | — |
FAQ
Is ACAT financially healthy?
NP Life Sciences Health Industry Group Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).
Does ACAT pay a dividend?
No, NP Life Sciences Health Industry Group Inc. does not currently pay a dividend.
How profitable is ACAT?
In FY2023, NP Life Sciences Health Industry Group Inc. had a net margin of -1.8% and a return on equity of -17.9%.
Source: SEC EDGAR filings · CIK 0001781726 · US · as of 2023-12-31. facts plus Stocktoria's own computed scores — not investment advice.